Fig. 2From: A double blind randomised controlled trial comparing standard dose of iron supplementation for pregnant women with two screen-and-treat approaches using hepcidin as a biomarker for ready and safe to receive ironConfidence interval approach to analysis of non-inferiority trialBack to article page